Key conversations focused on access to care, emerging technologies, GLP-1s, and topical analgesics.
Key conversations focused on access to care, emerging technologies, GLP-1s, and topical analgesics.
The November 3rd meeting will provide the public a chance to comment on fee schedule rules and other regulations.
As part of the proposal, the state has issued a stakeholder survey that will close October 22nd.
A workshop to streamline workers’ comp regulations will now take place October 12th.
Agenda topics include topicals, GLP-1 drugs, biologics, PPI and H2 blockers, and more.
The proposal would incorporate the latest ACOEM Guideline for knee disorders, and a public hearing is scheduled for October 16th.
The meeting will take place September 24th, with agenda topics including provision of coverage, benefits for injury or death, and occupational diseases.
Stakeholders can submit feedback on the research agenda through September 28th.
The proposed changes will have a 45-day public comment period for stakeholders to provide feedback.
Impacted drugs include physician-dispensed and repackaged drugs, topicals, compounds, and OTC medications.
Impacted items would include pharmacy and topical reimbursement, home health, prior authorization, and more.
Stakeholder feedback for the audit plan will be accepted until 5:00 PM CST on August 6th.
The meeting discussed issues that could affect pharmacy reimbursement, statutory provider definitions, and medical accessibility reporting.
Topics covered include a new AI innovation office, a remote interpreters program, and updates for rulemaking and audits.
The August 20th webinar will discuss the impact of PBM legislation on workers' compensation systems.
